A Systematic Review of the Expression, Signalling and Function of P2 Receptors in Primary Bone Cancer
Primary bone cancers are rare malignant diseases with significant morbidity and mortality. The treatment regimen relies on a combination of surgery (often involving amputation), chemotherapy and radiotherapy with outcomes dependent on localization of the tumour, grade, size and response to chemother...
Main Authors: | Luke Tattersall, Dan C Gagui, Victoria L Tippett, Norain B Ab Latif, Karan M Shah, Alison Gartland |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2022-04-01
|
Series: | Frontiers in Bioscience-Landmark |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/FBL/27/4/10.31083/j.fbl2704122 |
Similar Items
-
Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma
by: Guijun Xu, et al.
Published: (2021-02-01) -
Primary Osseous Malignancies of the Spine
by: Sisith Ariyaratne, et al.
Published: (2023-05-01) -
Proton Radiotherapy for Pediatric Sarcoma
by: Matthew M. Ladra, et al.
Published: (2014-01-01) -
Histopathological Study of Bone Tumours in 78 Cases from a Tertiary Care Hospital, Hyderabad
by: Bangaru Sandhya, et al.
Published: (2021-10-01) -
Prognostic factors for survival among patients with primary bone sarcomas of small bones
by: Wang Z, et al.
Published: (2018-05-01)